Vietnamese Balm — Benefits Deep Dive

Vietnamese balm (Elsholtzia ciliata, kinh giới in Vietnam, xiang ru in Chinese medicine) is claimed, traditionally, for colds and fever, for digestive upset, and — more recently and far more substantially — has become the subject of a genuine, patented, internationally published cardiovascular drug-development program built around its essential oil. This is an unusual shape for a Benefits section: the plant's oldest claim is its least-researched, and its most-researched property is one nobody in Vietnam, China, Korea or Japan ever traditionally claimed at all.

The single fact that governs everything below: no human being has ever been enrolled in a clinical trial of this plant, for any reason. What exists instead is a genuinely interesting, occasionally rigorous, entirely preclinical research base — rabbit hearts, anaesthetized pigs, rat tissue, mouse models, and a steadily growing body of cell-culture chemistry, much of it published in just the last two years. The four pages below take that research seriously enough to describe it in full, with real numbers, real methods, and the specific limits of each finding stated at the point where the finding is made, not hedged once in a preamble and then forgotten.

Table of Contents

1. Deep-Dive Articles
2. Evidence Ledger
3. Key Research: Colds, Fever and Digestion
4. Key Research: Cardiovascular Pharmacology
5. Key Research: Antimicrobial and Insecticidal Chemistry
6. Key Research: Anti-Inflammatory and Antioxidant Chemistry
7. External Resources
8. Connections

Deep-Dive Articles

Back to Table of Contents

Evidence Ledger

Ranked against the popular narrative rather than with it. The headline fact is item one, not buried at the bottom.

1. Absent: any human evidence, for anything. No trial, no case series, no pharmacokinetic study, for fever, cold symptoms, digestion, arrhythmia, blood pressure, inflammation, or any other claim on this site. This is the load-bearing fact for all four pages below.
2. Established, ex-vivo and whole-animal, cardiovascular: sodium-channel blockade, demonstrated in an isolated rabbit heart and independently confirmed in a living, anaesthetized pig by the same research collaboration. The single most rigorously replicated finding on this plant — and it is a safety caution, not a marketed benefit, on the main topic page.
3. Established, ex-vivo, vascular: alpha-1 adrenergic antagonism in isolated rat aorta and prostate tissue, with the same furan-ring chemistry implicated in the cardiac finding above. Cuts the same direction: real pharmacology, real caution.
4. Preliminary, in-vitro, convergent across four independent laboratories: suppression of inflammatory cytokines, nitric oxide and prostaglandin E2 in activated macrophages and mast cells, reported separately by groups in Lithuania, Vietnam (twice) and South Korea, using different extraction methods. Unusually strong replication for a preclinical finding; still zero whole-animal disease-model or human confirmation for any inflammatory condition.
5. Preliminary, in-vitro, single-paper, both from 2025: inhibition of human coronavirus (HCoV-OC43) replication via luteolin-7-O-glucoside, and suppression of inflammatory signalling in a viral-RNA-mimetic macrophage assay. Both cell-culture only; both papers' own authors describe the next step, in-vivo testing, as not yet done.
6. Preliminary, whole-animal, single-paper each: renal anti-fibrotic effect in a rat kidney-obstruction model (oral dosing, active drug comparator — one of the better-designed animal studies here) and improved gut motility and barrier function in a mouse constipation model using the water-based extract that actually matches traditional preparation.
7. Preliminary, in-vitro and agricultural: antibacterial activity against veterinary mastitis pathogens and stored-grain insect pests, aimed at replacing antibiotics in dairy herds and pesticides in grain silos — real science, explicitly not aimed at human infection.
8. Absent: dedicated antifungal potency data, oral pharmacokinetics of the essential oil, and any drug-interaction study — gaps worth stating precisely rather than leaving implicit.
9. Traditional: centuries of use for colds, chills and "summer-heat with dampness" digestive upset across Vietnam, China, Korea and Japan — a real, internally consistent traditional category, entirely disconnected from the cardiovascular pharmacology program that is this plant's largest modern research investment.

Back to Table of Contents

Key Research: Colds, Fever and Digestion

1. Kim JH, et al. Anti-inflammatory effects of Elsholtzia ciliata extract on Poly I:C-treated RAW264.7 cells. Journal of Ethnopharmacology. 2025. PubMed search.
2. Lee S, et al. Luteolin-7-O-glucoside from Elsholtzia ciliata extract inhibits the replication of coronavirus. PLoS One. 2025. PubMed search.
3. Wu J, et al. Aqueous extracts of Elsholtzia ciliata and Hovenia dulcis ameliorate loperamide-induced constipation in mice. Frontiers in Microbiology. 2025. PubMed search.
4. Zeng Z, et al. Rapid characterization of non-volatile phenolic compounds reveals the reliable chemical markers for authentication of traditional Chinese medicine Xiang-ru among confusing Elsholtzia species. Chinese Journal of Natural Medicines. 2024. PubMed search.
5. Full list, including the formula-substitution studies and the Andrographis/Pelargonium comparator trials, on the Colds, Fever and Digestive Complaints page.

Back to Table of Contents

Key Research: Cardiovascular Pharmacology

1. Mačianskienė R, et al. Antiarrhythmic Properties of Elsholtzia ciliata Essential Oil on Electrical Activity of the Isolated Rabbit Heart and Preferential Inhibition of Sodium Conductance. Biomolecules. 2020. PubMed search.
2. Zigmantaitė V, et al. Evaluation of the Cardiac Electrophysiological and Haemodynamic Effects of Elsholtzia ciliata Essential Oil on Swine. Pharmaceuticals. 2022. PubMed search.
3. Martišienė I, et al. Elsholtzia ciliata Essential Oil Exhibits a Smooth Muscle Relaxant Effect. Pharmaceuticals. 2023. PubMed search.
4. Cardiac Arrhythmia Suppression Trial (CAST) — why sodium-channel blockade is treated with particular caution in modern cardiology. PubMed search.
5. Full list, including the toxicology study and the Brugada-syndrome and alpha-1-blocker context, on the Cardiovascular Pharmacology and Safety page.

Back to Table of Contents

Key Research: Antimicrobial and Insecticidal Chemistry

1. Liang JY, et al. Toxicity and Synergistic Effect of Elsholtzia Ciliata Essential Oil and Its Main Components Against the Adult and Larval Stages of Tribolium Castaneum. Foods. 2020. PubMed search.
2. Song S, et al. Bioactivities and Synergistic Effect of Elsholtzia ciliata Essential Oil and Its Main Components against Lasioderma serricorne. Molecules. 2024. PubMed search.
3. Tinh NQ, et al. Preparation of nanoemulsions from Elsholtzia kachinensis and Elsholtzia ciliata essential oils via ultrasonic homogenization and their antibacterial and anticancer activities. RSC Advances. 2025. PubMed search.
4. Kobold U, et al. Terpenoids from Elsholtzia Species; Constituents of Essential Oil from a New Chemotype of Elsholtzia cristata. Planta Medica. 1987. PubMed search.
5. Full list, including the mastitis and pharmacognostic studies, on the Antimicrobial and Insecticidal Chemistry page.

Back to Table of Contents

Key Research: Anti-Inflammatory and Antioxidant Chemistry

1. Kim HH, et al. Elsholtzia ciliata inhibits mast cell-mediated allergic inflammation: role of calcium, p38 mitogen-activated protein kinase and nuclear factor-κB. Experimental Biology and Medicine. 2011. PubMed search.
2. Kim TW, et al. Elsholtzia ciliata (Thunb.) Hylander attenuates renal inflammation and interstitial fibrosis via regulation of TGF-β and Smad3 expression on unilateral ureteral obstruction rat model. Phytomedicine. 2016. PubMed search.
3. Nguyen DTX, et al. Effect of Non-Volatile Constituents of Elsholtzia ciliata from Southern Vietnam on Reactive Oxygen Species and Nitric Oxide Release in Macrophages. Chemistry & Biodiversity. 2021. PubMed search.
4. Wang F, et al. Elsholtzia ciliata (Thunb.) Hyland: A Review of Phytochemistry and Pharmacology. Molecules. 2022. The comprehensive review underlying all four pages in this section. PubMed search.
5. Full list, including the recurring luteolin-7-O-glucoside thread and the rosmarinic-acid borrowed-evidence discussion, on the Anti-Inflammatory and Antioxidant Chemistry page.

Back to Table of Contents

External Resources

• PubMed — the US National Library of Medicine's index of the biomedical literature; every citation across these five pages resolves here.
• NCCIH — Herbs at a Glance — plain-language summaries from the US National Center for Complementary and Integrative Health.
• World Flora Online — the accepted-name reference for checking plant identity and synonymy, relevant given how many Elsholtzia species are traditionally conflated.
• LiverTox (NIH) — the reference on herb- and drug-induced liver injury.
• European Medicines Agency — Herbal Medicinal Products — the regulatory framework for traditional-use registration referenced throughout this site.

Back to Table of Contents

Connections

• All Herbs
• Vietnamese Balm (Main Page)
• Colds, Fever and Digestive Complaints
• Cardiovascular Pharmacology and Safety
• Antimicrobial and Insecticidal Chemistry
• Anti-Inflammatory and Antioxidant Chemistry
• Perilla — tía tô, Vietnamese balm's constant companion on the herb plate.
• Perilla Benefits
• Houttuynia — diếp cá, fish mint, the third fixture of the Vietnamese raw-herb plate.
• Houttuynia Benefits — a strikingly similar evidence shape on a neighbouring herb.
• Lemon Balm — the European Lamiaceae with the same lemon note and a far larger clinical literature.
• Andrographis for Cold and Flu — the comparator herb with actual placebo-controlled trials.
• Elderberry for Cold and Flu — another, with its own randomised-trial literature.
• Arrhythmia
• Common Cold
• Luteolin

Back to Table of Contents